hepatocellular carcinoma

This Week in PNAS

In PNAS this week: sand rat genome assembly, algorithm for human leukocyte antigen typing from short-read data, and more.

Researchers combined a microfluidic technology called the CTC-iChip with digital PCR to potentially improve cancer detection in hepatocellular carcinoma patients.

This Week in PNAS

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

In Nucleic Acids Research this week: CHOPCHOP web tool update, human retina transcriptional atlas, and more.

This Week in PLOS

In PLOS this week: DNA barcodes for identifying plants in herbal remedies, copy number and DNA methylation patterns in HBV-linked liver cancer, and more.

An INSERM-led team has uncovered new hepatocellular carcinoma mutational signatures that reflect exposure to certain disease risk factors.

The data also indicate early signs of clinical activity in certain patients.

NEW YORK (GenomeWeb) – A team from Japan and the US used a combination of whole-genome sequencing, exome sequencing, and "oncovirome" sequencing to scrutinize matched tumor and normal samples from more than 500 individuals from different populations who had a form of liver cancer called hepatocel

SAN DIEGO (GenomeWeb News) — MicroRNAs are cropping up in different aspects of cancer research, according to a session at the American Association for Cancer Research annual meeting held here this week.

NEW YORK (GenomeWeb News) – Trovagene today said that it has entered into an R&D agreement with PerkinElmer Health Sciences to design an assay for evaluating a patient's risk of developing hepatocellular carcinoma.

Pages

ScienceInsider reports that a new security policy at the US Food and Drug Administration may prevent foreign nationals from working there.

WBUR in Boston looks into Orig3n's genetic fitness assessments to find more research is needed.

Cleveland.com reports that getting a DNA profile removed from a law enforcement database can be tricky.

In PNAS this week: de novo mutations contribute to non-syndromic craniosynostosis, fungal tree of life, and more.